242 related articles for article (PubMed ID: 26833741)
41. Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome.
Pestieau SR; Esquivel J; Sugarbaker PH
Ann Surg Oncol; 2000 Apr; 7(3):199-203. PubMed ID: 10791850
[TBL] [Abstract][Full Text] [Related]
42. Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy.
Gleeson EM; Feldman R; Mapow BL; Mackovick LT; Ward KM; Morano WF; Rubin RR; Bowne WB
Am J Clin Oncol; 2018 Aug; 41(8):777-783. PubMed ID: 28263231
[TBL] [Abstract][Full Text] [Related]
43. Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study.
Baratti D; Kusamura S; Milione M; Pietrantonio F; Caporale M; Guaglio M; Deraco M
Ann Surg Oncol; 2016 Dec; 23(13):4222-4230. PubMed ID: 27352203
[TBL] [Abstract][Full Text] [Related]
44. Laparoscopic evacuation of mucinous ascites for palliation of pseudomyxoma peritonei.
Kelly KJ; Baumgartner JM; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1722-5. PubMed ID: 25395145
[TBL] [Abstract][Full Text] [Related]
45. Mitogen-activated protein kinase inhibition reduces mucin 2 production and mucinous tumor growth.
Dilly AK; Song X; Zeh HJ; Guo ZS; Lee YJ; Bartlett DL; Choudry HA
Transl Res; 2015 Oct; 166(4):344-54. PubMed ID: 25890193
[TBL] [Abstract][Full Text] [Related]
46. [Pseudomyxoma peritonei (PMP) secondary to mucinous carcinoma of the ovary: a case study].
Belhamidi MS; Zorkani Y; Krimou H; Kaoukabi A; Menfaa M; Sakit F; Choho K
Pan Afr Med J; 2019; 33():283. PubMed ID: 31692896
[TBL] [Abstract][Full Text] [Related]
47. A unique presentation of superinfected pseudomyxoma peritonei secondary to a low-grade appendiceal mucinous neoplasm.
Sullivan BJ; Bolton N; Sarpel U; Magge D
World J Surg Oncol; 2019 Feb; 17(1):34. PubMed ID: 30777068
[TBL] [Abstract][Full Text] [Related]
48. Significance of epithelial cell clusters in pseudomyxoma peritonei.
Badyal RK; Khairwa A; Rajwanshi A; Nijhawan R; Radhika S; Gupta N; Dey P
Cytopathology; 2016 Dec; 27(6):418-426. PubMed ID: 27121698
[TBL] [Abstract][Full Text] [Related]
49. Pulmonary giant cell carcinoma associated with pseudomyxoma peritonei.
Goldin M; Li J; Amirrezvani A; Riker D
J Bronchology Interv Pulmonol; 2012 Jan; 19(1):50-3. PubMed ID: 23207264
[TBL] [Abstract][Full Text] [Related]
50. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin.
Delhorme JB; Severac F; Averous G; Glehen O; Passot G; Bakrin N; Marchal F; Pocard M; Lo Dico R; Eveno C; Carrere S; Sgarbura O; Quenet F; Ferron G; Goéré D; Brigand C;
Br J Surg; 2018 May; 105(6):668-676. PubMed ID: 29412465
[TBL] [Abstract][Full Text] [Related]
51. Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei.
Legué LM; Creemers GJ; de Hingh IHJT; Lemmens VEPP; Huysentruyt CJ
Clin Colorectal Cancer; 2019 Mar; 18(1):1-7. PubMed ID: 30611664
[TBL] [Abstract][Full Text] [Related]
52. Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei.
Bjersand K; Mahteme H; Sundström Poromaa I; Andréasson H; Graf W; Larsson R; Nygren P
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S810-6. PubMed ID: 26193962
[TBL] [Abstract][Full Text] [Related]
53. Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis.
Shetty S; Thomas P; Ramanan B; Sharma P; Govindarajan V; Loggie B
J Surg Res; 2013 Mar; 180(1):97-103. PubMed ID: 23199549
[TBL] [Abstract][Full Text] [Related]
54. Pseudomyxoma peritonei: the 'controversial' disease.
Galani E; Marx GM; Steer CB; Culora G; Harper PG
Int J Gynecol Cancer; 2003; 13(4):413-8. PubMed ID: 12911716
[TBL] [Abstract][Full Text] [Related]
55. Glycomic Profiling Highlights Increased Fucosylation in Pseudomyxoma Peritonei.
Saarinen L; Nummela P; Leinonen H; Heiskanen A; Thiel A; Haglund C; Lepistö A; Satomaa T; Hautaniemi S; Ristimäki A
Mol Cell Proteomics; 2018 Nov; 17(11):2107-2118. PubMed ID: 30072579
[TBL] [Abstract][Full Text] [Related]
56. Pseudomyxoma peritonei induced by low-grade appendiceal mucinous neoplasm accompanied by rectal cancer: a case report and literature review.
Ning S; Yang Y; Wang C; Luo F
BMC Surg; 2019 Apr; 19(1):42. PubMed ID: 31023277
[TBL] [Abstract][Full Text] [Related]
57. Pseudomyxoma peritonei (PMP) and its therapy - 20 years experience of a single surgical department.
Bartoška P; Antoš F; Vítek P; Marx J; Holečková P; Novotný M; Kengbaeva M
Rozhl Chir; 2020; 99(4):159-166. PubMed ID: 32545978
[TBL] [Abstract][Full Text] [Related]
58. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis.
Ronnett BM; Yan H; Kurman RJ; Shmookler BM; Wu L; Sugarbaker PH
Cancer; 2001 Jul; 92(1):85-91. PubMed ID: 11443613
[TBL] [Abstract][Full Text] [Related]
59. Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix.
Honoré C; Caruso F; Dartigues P; Benhaim L; Chirica M; Goéré D; Elias D
Anticancer Res; 2015 Sep; 35(9):4943-7. PubMed ID: 26254392
[TBL] [Abstract][Full Text] [Related]
60. [Prognostic value of clinical and pathological characteristics in 48 women with pseudomyxoma peritonei].
Lu YY; Guo AT; Liu AJ; Shi HY
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):595-601. PubMed ID: 24199925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
